Industries — page 20
FTAI Infrastructure Posts Record Rail Earnings
Railroad Adjusted EBITDA reached $42.4 million as the company booked $76.1 million of group Adjusted EBITDA and a $63.2 million impairment.
Energy Recovery's Megaproject Sales Collapse After Iran War
Second-quarter revenue fell 57% to $12.0 million as megaproject sales dropped 82% and the company posted a $3.2 million net loss.
Emergent Cuts Full-Year Outlook After Naloxone Impairment
Second-quarter revenue reached $234.3 million as medical countermeasures rose, while the company booked a $191.3 million NARCAN impairment and lowered full-year revenue guidance to $645 million to $675 million.
Disney Profit Growth Accelerates as Experiences Lead
Quarterly revenue rose 7% to $25.25 billion, holding its prior-quarter growth rate.
DHI Raises Dice Margin Outlook, Reaffirms Revenue Guidance
ClearanceJobs bookings rose 24% to $14.3 million as the company lifted Dice's full-year Adjusted EBITDA margin target to 24% from 22%.
CVS Health Raises Full-Year Profit Guidance on Health Care Gains
The healthcare giant increased its full-year 2026 adjusted EPS guidance to a range of $7.90 to $8.10.
Cencora Raises Outlook as OneOncology Expands Margins
Fiscal third-quarter revenue rose 5.1% to $84.8 billion as specialty-drug volumes increased.
Coherus Oncology Restores LOQTORZI Growth After Weather-Weighed Quarter
LOQTORZI net revenue reached $13.6 million in the second quarter, up 15% from $11.8 million in the first quarter.
BillionToOne’s Revenue Growth Slowed for a Second Straight Quarter
The molecular diagnostics company reported $109.4 million in second-quarter revenue and maintained its full-year forecast after two successive increases.
BioAge Doses First Patient in BGE-102 Phase 2 Trial
The company said QUELL-CV topline data are expected in the second half of 2026, with cash of about $381.3 million funding operations through 2029.
Biodesix Test Volume Growth Accelerates
Second-quarter revenue was $26.9 million, up 34%, as diagnostic test volumes rose 38% to 20,900.
Alto Extends Profit Streak to a Fourth Quarter
Second-quarter net income attributable to common stockholders was $11.4 million, or $0.15 a share, after a $1.9 million gross loss a year earlier.
Akebia Turns to a Loss as Auryxia Recedes
Vafseo net product sales reached $21.3 million in the second quarter, up 34% from the first quarter, as more than 10,500 patients were on therapy.
Intersnack Group to Buy Utz Brands in All-Cash Deal
The acquisition will take the U.S. snack manufacturer private, with Intersnack Group and the Rice and Lissette Family Entities each holding a 50% stake.
Motorola Solutions to Buy D-Fend Solutions in $1.5 Billion Deal
The acquisition aims to integrate industry-leading counter-drone technology into Motorola's public safety and security portfolio.
LCI Industries, Patrick Industries Agree to All-Stock Merger
The combination pairs Lippert's structural components business with Patrick's aftermarket distribution network to create an $8.1 billion revenue platform serving RV, marine, powersports and housing OEMs.
Howard Hughes to Buy Vantage Group in $2.1 Billion All-Cash Deal
The insurer acquisition gives Howard Hughes a second operating platform alongside its communities business, formalizing Bill Ackman's push to remake the company as a diversified holding company.
Gran Tierra to Sell Oil Business in $1.33 Billion Asset Deal
The divestiture would strengthen Gran Tierra’s balance sheet and fund growth across its retained assets.
Eton Pharmaceuticals to Acquire U.S. Rights to ASN-001 From Auson
The asset purchase pairs a late-stage hemangioma candidate with Eton's existing HEMANGEOL franchise, extending a commercial infrastructure built for pediatric dermatology.
CoreCivic Sells Two Facilities in $734 Million Asset Deal
The prison operator planned to direct the proceeds toward corporate purposes including debt reduction and share repurchases.
Central Garden & Pet to Buy TRIXIE in Up to €400 Million Deal
The acquisition would establish a scaled European platform and lift Central’s international sales exposure to about 10%.
Mubadala Capital Consortium to Buy Clear Channel Outdoor for $6.2 Billion
The all-cash take-private, first struck in February at $2.43 a share, heads toward a third-quarter close after clearing a stockholder vote and a CFIUS review.
Blue Bird to Buy Detroit Chassis Plant Assets in Ford Tie-Up
Blue Bird agreed to acquire the assets of Detroit Chassis LLC's Detroit Assembly Plant as part of an expanded collaboration with Ford, a move it says opens $1.4 billion of new addressable market.
Blue Bird to Buy Detroit Chassis Assets in Ford Collaboration Deal
The asset acquisition is part of a broader agreement with Ford Motor Company to design and commercialize the next generation of F-53 and F-59 commercial stripped chassis.
GLP-1 Shift: Branded Access and Oral Formulations Gain Ground
Virtual care providers and biotech firms are pivoting toward FDA-approved branded therapies and oral delivery systems to stabilize supply and improve patient persistence.
AI Compute Shifts Toward Modular and Co-Located Power
Infrastructure providers are pivoting to containerized data centers and direct energy asset co-location to bypass grid bottlenecks.
Exagen Raises 2026 Revenue Outlook After Record Quarter
Second-quarter revenue reached a record $19.9 million as the company lifted full-year guidance to $72 million to $75 million.
Wayfair Revenue Growth Accelerates as US Sales Gain Momentum
The e-commerce retailer reported total net revenue of $3.5 billion for the second quarter.
USANA Swings to Loss After Hiya Goodwill Impairment
The health-products company booked a $29.1 million preliminary Hiya goodwill charge and cut fiscal 2026 sales guidance to $910 million.
Wheels Up Completes Fleet Modernization as Charter Bookings Fall
GAAP revenue was $182.0 million in the second quarter, down 4% year over year, while Adjusted EBITDAR loss narrowed 27% to $19.9 million.
Superior Group Confirms 2026 Outlook After Apparel Impairment
Adjusted earnings were $0.21 a share after a $2.6 million Healthcare Apparel tradename charge that left reported profit at $0.08 a share.
Rockwell Automation Raises Full-Year Outlook as Software Sales Climb
The industrial automation provider increased its fiscal 2026 diluted EPS guidance to a range of $12.72 to $13.02.
Pfizer Swings to Loss on $4.3 Billion Impairment as Growth Slows
Pfizer posted a reported loss of $(0.04) a share in the second quarter after taking $4.3 billion in non-cash intangible impairments, even as it raised full-year revenue guidance by $500 million.
PAMT Reverses First-Quarter Revenue Decline
Second-quarter operating revenue reached $164.7 million as the truckload carrier booked a $3.1 million auto-liability accrual.
Niagen Launches NB4168 Drug Candidate and Telehealth Platform
Second-quarter net sales were $29.8 million, including $24.2 million from Tru Niagen, as the company introduced NB4168 and a Niagen Plus telehealth channel.
Merck Raises Sales Outlook as Acquisition Charge Drives Loss
Quarterly sales increased to $16.607 billion as cancer-drug demand offset declining diabetes revenue.
McDonald’s Sales Growth Slows as U.S. Traffic Turns Negative
Second-quarter revenue increased 4% to $7.10 billion as growth moderated across McDonald’s major markets.
LoanDepot Narrows Loss as Home Equity Mix Lifts Margin
Second-quarter revenue reached $337 million as pull-through weighted gain on sale margin rose to 345 basis points.
InfuSystem Oncology Crosses $20 Million in a Quarter
Net revenues reached $36.9 million, up 2.6% from a year earlier, and Adjusted EBITDA rose 7.6% to $8.6 million.
Idexx Raises Outlook as Margins Widen
Second-quarter revenue reached $1.217 billion as stronger profitability supported a higher full-year forecast.
Horizon NAV Falls After Single-Name Unrealized Losses
Net asset value was $6.23 a share at June 30, 2026, after $38.5 million of net unrealized depreciation, or $0.59 a share.
Finance of America Completes Onity HECM Servicing Purchase
Funded volume reached $730 million as the company closed the Onity HECM servicing deal and posted a $29 million GAAP loss.
8x8 Extends Revenue Growth Into Fiscal 2027
The communications platform posted record service revenue of $185.3 million and total revenue of $190.2 million in the quarter ended June 30, 2026.
Crexendo's Second-Quarter Revenue Growth Accelerates
Total revenue rose 49% to $24.6 million as service sales and adjusted EBITDA expanded after the Estech Systems deal.
Core Molding Gross Margin Reaches 20.3% of Sales
Second-quarter net revenue was $62.7 million as truck product sales stayed soft and tooling project revenue fell to $1.8 million.
Caterpillar hits record quarterly revenue as construction demand accelerates
The industrial manufacturer generated $20.5 billion in sales during the second quarter, the first time the company has exceeded $20 billion in a single period.
Bed Bath & Beyond Extends Revenue Growth Into a Second Quarter
Net revenue reached $361 million, up 28.0% year-over-year, after a 6.9% increase in the first quarter, as the company added The Brand House Collective.
Angel Oak's Second-Quarter Net Interest Income Growth Slows
Net interest income was $10.7 million in the quarter ended June 30, 2026, up 8% from a year earlier, after 20.1% year-over-year growth in the first quarter.
Archer-Daniels-Midland Raises Outlook as Oilseed Profit Rebounds
Revenue increased 7% to $22.68 billion as the oilseed business returned to growth.
Z Squared to Finalize Paradox Data Buy in Up-to-$25 Million Deal
The definitive agreement ties 80% of the consideration to power-delivery milestones at Z Squared's Union County Campus, extending the milestone-gated acquisition structure that has defined its Phase 1 buildout.